$ONMD

Yu Jeffrey purchased $100K of ONMD

Yu Jeffrey (Chief Medical Officer) purchased 172,414 shares of OneMedNet Corp (ONMD) at $0.58 ($0.10M total) on 2026-06-16.

Original reporting
SEC EDGAR · Yu Jeffrey
Published Jun 17, 2026, 11:38 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 17, 2026, 12:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ONMD
Bullish
medium confidence
Mentioned
$ONMD
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ONMDBullishLow
01

Why it matters

The newest fact is the CMO/10% owner’s open-market purchase details (shares, price, total value, and post-transaction holdings). This can influence short-term sentiment but does not provide new operating or financial guidance.

02

Market read

Traders may monitor ONMD for follow-through in sentiment/flow, but the filing alone is unlikely to drive a fundamental repricing.

03

What to watch

The filing notes no pre-arranged 10b5-1 plan; traders may still discount the signal if the buy size is small relative to float or if prior insider patterns show mixed behavior.

Relevance 5/10Novelty 6/10Timing: Filed 2026-06-17 (transaction dated 2026-06-16)

Background

The article is an SEC Form 4 insider transaction disclosure for OneMedNet (ONMD).

Company-level read

Ticker impact

$ONMDBullishMedium confidence
Context

OneMedNet CMO/10% owner Yu Jeffrey filed an open-market purchase of 172,414 shares at $0.5800 on 2026-06-16.

Expected impact

Likely modest, short-lived sentiment lift; no clear directional catalyst beyond the filing.

Evidence & confidence

The article discloses a new insider buy (Form 4) with specific size/price, but it does not include earnings, guidance, trials, contracts, or regulatory actions.

Market effects

No sector-wide read-across; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine (e.g., liquidity needs or diversification) and may not signal near-term operational improvement.

Key entities

  • OneMedNet Corp

    Subject of the Form 4 insider transaction; CMO/10% owner purchased shares on 2026-06-16.

  • Yu Jeffrey

    Chief Medical Officer, Officer/Director/10% Owner; executed an open-market purchase disclosed on Form 4.

Related articles